These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


147 related items for PubMed ID: 29966986

  • 1. In vitro combinatorial anti-proliferative and immunosuppressive effects of Brucea javanica extract with CX-4945 and imatinib in human T-cell acute lymphoblastic leukemia cells.
    Jung JI, Kim SY, Park KY, Sydara K, Lee SW, Kim SA, Kim J.
    Biomed Pharmacother; 2018 Oct; 106():403-410. PubMed ID: 29966986
    [Abstract] [Full Text] [Related]

  • 2. Synergistic therapeutic effect of diethylstilbestrol and CX-4945 in human acute T-lymphocytic leukemia cells.
    Jung JI, Park KY, Kim SA, Kim J.
    Biomed Pharmacother; 2018 Feb; 98():357-363. PubMed ID: 29275177
    [Abstract] [Full Text] [Related]

  • 3. Anti-Proliferative Effect of Allium senescens L. Extract in Human T-Cell Acute Lymphocytic Leukemia Cells.
    Kim J, Lee DH, Badamtsetseg B, Lee S, Kim SA.
    Molecules; 2020 Dec 23; 26(1):. PubMed ID: 33374788
    [Abstract] [Full Text] [Related]

  • 4. The apoptotic effects of Brucea javanica fruit extract against HT29 cells associated with p53 upregulation and inhibition of NF-κB translocation.
    Bagheri E, Hajiaghaalipour F, Nyamathulla S, Salehen N.
    Drug Des Devel Ther; 2018 Dec 23; 12():657-671. PubMed ID: 29636600
    [Abstract] [Full Text] [Related]

  • 5. Marsdenia tenacissimae extraction (MTE) inhibits the proliferation and induces the apoptosis of human acute T cell leukemia cells through inactivating PI3K/AKT/mTOR signaling pathway via PTEN enhancement.
    Wang Y, Chen B, Wang Z, Zhang W, Hao K, Chen Y, Li K, Wang T, Xie Y, Huang Z, Tong X.
    Oncotarget; 2016 Dec 13; 7(50):82851-82863. PubMed ID: 27756877
    [Abstract] [Full Text] [Related]

  • 6. Synergistic cytotoxic effects of bortezomib and CK2 inhibitor CX-4945 in acute lymphoblastic leukemia: turning off the prosurvival ER chaperone BIP/Grp78 and turning on the pro-apoptotic NF-κB.
    Buontempo F, Orsini E, Lonetti A, Cappellini A, Chiarini F, Evangelisti C, Evangelisti C, Melchionda F, Pession A, Bertaina A, Locatelli F, Bertacchini J, Neri LM, McCubrey JA, Martelli AM.
    Oncotarget; 2016 Jan 12; 7(2):1323-40. PubMed ID: 26593250
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Brucea javanica: A review on anticancer of its pharmacological properties and clinical researches.
    Li KW, Liang YY, Wang Q, Li Y, Zhou SJ, Wei HC, Zhou CZ, Wan XH.
    Phytomedicine; 2021 Jun 12; 86():153560. PubMed ID: 33858739
    [Abstract] [Full Text] [Related]

  • 9. Anti-inflammatory activity of ethyl acetate fraction of the seeds of Brucea Javanica.
    Yang J, Li S, Xie C, Ye H, Tang H, Chen L, Peng A.
    J Ethnopharmacol; 2013 May 20; 147(2):442-6. PubMed ID: 23538165
    [Abstract] [Full Text] [Related]

  • 10. Inhibition of protein kinase CK2 by CX-5011 counteracts imatinib-resistance preventing rpS6 phosphorylation in chronic myeloid leukaemia cells: new combined therapeutic strategies.
    Salizzato V, Borgo C, Cesaro L, Pinna LA, Donella-Deana A.
    Oncotarget; 2016 Apr 05; 7(14):18204-18. PubMed ID: 26919095
    [Abstract] [Full Text] [Related]

  • 11. Anti-proliferative effect of RCE-4 from Reineckia carnea on human cervical cancer HeLa cells by inhibiting the PI3K/Akt/mTOR signaling pathway and NF-κB activation.
    Bai C, Yang X, Zou K, He H, Wang J, Qin H, Yu X, Liu C, Zheng J, Cheng F, Chen J.
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Jun 05; 389(6):573-84. PubMed ID: 26935715
    [Abstract] [Full Text] [Related]

  • 12. Combined Casein Kinase II inhibition and epigenetic modulation in acute B-lymphoblastic leukemia.
    Richter A, Roolf C, Hamed M, Gladbach YS, Sender S, Konkolefski C, Knübel G, Sekora A, Fuellen G, Vollmar B, Murua Escobar H, Junghanss C.
    BMC Cancer; 2019 Mar 06; 19(1):202. PubMed ID: 30841886
    [Abstract] [Full Text] [Related]

  • 13. Seed oil of Brucea javanica induces apoptosis through the PI3K/Akt signaling pathway in acute lymphocytic leukemia Jurkat cells.
    Zhang H, Yin SL, Wang LH, Jia LN, Su GY, Liu XQ, Zhou F, Breslin P, Meng R, Li QY, Yang JY, Wu CF.
    Chin J Nat Med; 2021 Aug 06; 19(8):608-620. PubMed ID: 34419260
    [Abstract] [Full Text] [Related]

  • 14. Anti-inflammatory effects of Brucea javanica oil emulsion by suppressing NF-κB activation on dextran sulfate sodium-induced ulcerative colitis in mice.
    Huang YF, Zhou JT, Qu C, Dou YX, Huang QH, Lin ZX, Xian YF, Xie JH, Xie YL, Lai XP, Su ZR.
    J Ethnopharmacol; 2017 Feb 23; 198():389-398. PubMed ID: 28119098
    [Abstract] [Full Text] [Related]

  • 15. Antiproliferative and apoptosis-inducing activity of Brucea javanica extract on human carcinoma cells.
    Lau FY, Chui CH, Gambari R, Kok SH, Kan KL, Cheng GY, Wong RS, Teo IT, Cheng CH, Wan TS, Chan AS, Tang JC.
    Int J Mol Med; 2005 Dec 23; 16(6):1157-62. PubMed ID: 16273300
    [Abstract] [Full Text] [Related]

  • 16. Tetrandrine and cepharanthine induce apoptosis through caspase cascade regulation, cell cycle arrest, MAPK activation and PI3K/Akt/mTOR signal modification in glucocorticoid resistant human leukemia Jurkat T cells.
    Xu W, Wang X, Tu Y, Masaki H, Tanaka S, Onda K, Sugiyama K, Yamada H, Hirano T.
    Chem Biol Interact; 2019 Sep 01; 310():108726. PubMed ID: 31255635
    [Abstract] [Full Text] [Related]

  • 17. Phytochemical and biological activities of an anticancer plant medicine: Brucea javanica.
    Zhao L, Li C, Zhang Y, Wen Q, Ren D.
    Anticancer Agents Med Chem; 2014 Mar 01; 14(3):440-58. PubMed ID: 24066797
    [Abstract] [Full Text] [Related]

  • 18. [Effect of Brucea Javanica Oil Emulsion on the Invasiveness of Glioma Cells and Its Possible Mechanism].
    Qin LJ, Jia YS, Zhao XQ, Zhang T, Zhang W, Sun N.
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2016 May 01; 47(3):347-50. PubMed ID: 27468478
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Triple Akt inhibition as a new therapeutic strategy in T-cell acute lymphoblastic leukemia.
    Cani A, Simioni C, Martelli AM, Zauli G, Tabellini G, Ultimo S, McCubrey JA, Capitani S, Neri LM.
    Oncotarget; 2015 Mar 30; 6(9):6597-610. PubMed ID: 25788264
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.